Cancer Associated Thrombosis
Springer International Publishing (Verlag)
978-3-030-25575-6 (ISBN)
- Titel wird leider nicht erscheinen
- Artikel merken
Venous thromboembolism (VTE) is a common occurrence in patients with malignant disease. Prevention of VTE is the ultimate goal. Acute VTE is treated with anticoagulant therapy to prevent recurrent thrombosis, including potentially fatal pulmonary embolism (PE). The risk of recurrent thrombosis and the risk of anticoagulant-induced bleeding are increased in cancer patients compared to non-cancer patient. Every cancer patient should be individually assessed for the risk of VTE or the risk of recurrence of VTE and the balance between thrombosis and bleeding, weighed up, for each person. The book addresses all these key issues.
The patient experience is a focus throughout the book. The table of contents maps the 'real life' cancer-associated thrombosis patient pathway for some patients.
Annie Young is Emerita Professor of Nursing at Warwick Medical School, University of Warwick, UK and Honorary Nurse Consultant, University Hospitals Coventry and Warwickshire, having recently retired. Annie now works part-time at the University, initiating and implementing research projects and as a mentor in UHCW, building the research capacity in the NHS Trust. Her research portfolio encompasses supportive care for cancer patients, predominantly on the management of cancer-associated thrombosis and including prevention of chemotherapy-induced alopecia and nausea and vomiting. Rehabilitation for cancer patients, new technologies for monitoring side effects of cancer therapies and cancer-associated cognitive impairment are special interests. Annie visits low resource countries in Africa to support their oncology nursing and patient care programmes and to partner in research.
ForewordProf Lord Ajay Kakkar
Chapter 1. Introduction - Scope of the Problem; Where have we come from?Annie Young, Mark Levine
Chapter 2. PathophysiologyAnna Falanga
Chapter 3. Screening for occult cancer in unprovoked thrombosis
Nancy McDonald, Marc Carrier
Chapter 4. CAT - Personal Experiences Sara Heyward, Usman Malik, Simon Noble
Chapter 5. Clinical Challenges of CAT: Incidental PE Farzana Haque; Anthony Maraveyas, Usman Malik, Simon Noble, Ismail Elalamy and AHP
Chapter 6. Risk Assessment for CAT in ClinicMailey Wilks, Alok Khorana
Chapter 7. ThromboprophylaxisFarzana Haque, Anthony Maraveyas
Chapter 8. TreatmentAnnie Young, Celia Diez De Los Rios De La Serna
Chapter 9. Biomarkers for CAT
Annie Young, Nicole Kuderer
Chapter 10. Cost of CATAnnie Young, Gary Lyman
Chapter 11. CAT GuidelinesEmma Gee, Julia Czuprynska
Chapter 12. Improving the Service - CAT Pathway - Nursing and Pharmacist - Led Services Nathan Jones, Sophie Didcott
Chapter 13. The FutureAnnie Young
Erscheint lt. Verlag | 26.2.2023 |
---|---|
Zusatzinfo | Approx. 200 p. 40 illus. in color. |
Verlagsort | Cham |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
Medizin / Pharmazie ► Pflege | |
Schlagworte | Anticoagulants • Bleeding • Deep vein thrombosis • Malignancy • Pulmonary embolism |
ISBN-10 | 3-030-25575-1 / 3030255751 |
ISBN-13 | 978-3-030-25575-6 / 9783030255756 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich